Adagene Inc. (ADAG) stock
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.48−0.12 (-7.50%)
Close on Nov 17, 2026Market cap $87.66MP/E –Yield –
Adagene price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Adagene's price to sales ratio was 23.3× on Nov 11, 2026, against 7.1× a year earlier. Over the last 5 years it ranged from 4.8× to 425.2×, with a median of 10.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 23.3× | +16.8 |
| 2025 | Feb 28, 2025 | 6.5× | +0.5 |
| 2024 | Dec 31, 2024 | 6.1× | −5.2 |
| 2023 | Dec 29, 2023 | 11.2× | +4.1 |
| 2022 | Dec 30, 2022 | 7.1× | −184.0 |
| 2021 | Dec 31, 2021 | 191.1× | – |
See a number that looks wrong?